Hahn Brian M.
- SEC CIK
- 0001589711
No open-market purchases or sales filed in the past year.
Current role at each company
- CBIO Crescent Biopharma, Inc.SVP Finance, CFOas of Jun 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hahn Brian M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 (view filing)4:15 PM ET | Jun 18 | 2 days | Hahn Brian M.SVP Finance, CFO | PPurchase | +17.5K | $0.2477 | +$4.33K | +32.9%70.6K after | |
| May 18, 2023 (view filing) | May 17 | 1 day | Hahn Brian M.SVP Finance, CFO | SSale | −3.70K | $1.95 | −$7.21K | −6.5%53.1K after | |
| Nov 14, 2022 (view filing) | Nov 11 | 3 days | Hahn Brian M.SVP Finance, CFO | PPurchase | +20.0K | $1.06 | +$21.2K | +54.3%56.8K after | |
| Mar 10, 2022 (view filing) | Mar 9 | 1 day | Hahn Brian M.SVP Finance, CFO | SSale | −2.92K | $1.09 | −$3.18K | −7.3%36.8K after |